Matches in SemOpenAlex for { <https://semopenalex.org/work/W4381432775> ?p ?o ?g. }
- W4381432775 endingPage "1772" @default.
- W4381432775 startingPage "1772" @default.
- W4381432775 abstract "Chronic inflammation contributes to the pathogenesis of many diseases, including apparently unrelated conditions such as metabolic disorders, cardiovascular diseases, neurodegenerative diseases, osteoporosis, and tumors, but the use of conventional anti-inflammatory drugs to treat these diseases is generally not very effective given their adverse effects. In addition, some alternative anti-inflammatory medications, such as many natural compounds, have scarce solubility and stability, which are associated with low bioavailability. Therefore, encapsulation within nanoparticles (NPs) may represent an effective strategy to enhance the pharmacological properties of these bioactive molecules, and poly lactic-co-glycolic acid (PLGA) NPs have been widely used because of their high biocompatibility and biodegradability and possibility to finely tune erosion time, hydrophilic/hydrophobic nature, and mechanical properties by acting on the polymer's composition and preparation technique. Many studies have been focused on the use of PLGA-NPs to deliver immunosuppressive treatments for autoimmune and allergic diseases or to elicit protective immune responses, such as in vaccination and cancer immunotherapy. By contrast, this review is focused on the use of PLGA NPs in preclinical in vivo models of other diseases in which a key role is played by chronic inflammation or unbalance between the protective and reparative phases of inflammation, with a particular focus on intestinal bowel disease; cardiovascular, neurodegenerative, osteoarticular, and ocular diseases; and wound healing." @default.
- W4381432775 created "2023-06-21" @default.
- W4381432775 creator A5011945658 @default.
- W4381432775 creator A5017114776 @default.
- W4381432775 creator A5030390675 @default.
- W4381432775 creator A5032635291 @default.
- W4381432775 creator A5043387826 @default.
- W4381432775 creator A5046269732 @default.
- W4381432775 creator A5048021304 @default.
- W4381432775 creator A5063681638 @default.
- W4381432775 creator A5067397711 @default.
- W4381432775 creator A5067778460 @default.
- W4381432775 creator A5083026629 @default.
- W4381432775 date "2023-06-20" @default.
- W4381432775 modified "2023-10-16" @default.
- W4381432775 title "Use of Poly Lactic-co-glycolic Acid Nano and Micro Particles in the Delivery of Drugs Modulating Different Phases of Inflammation" @default.
- W4381432775 cites W1008398044 @default.
- W4381432775 cites W1576591022 @default.
- W4381432775 cites W1691644051 @default.
- W4381432775 cites W1843658968 @default.
- W4381432775 cites W1928785183 @default.
- W4381432775 cites W1963986494 @default.
- W4381432775 cites W1965395695 @default.
- W4381432775 cites W1968848000 @default.
- W4381432775 cites W1969880445 @default.
- W4381432775 cites W1970771505 @default.
- W4381432775 cites W1971448220 @default.
- W4381432775 cites W1971917935 @default.
- W4381432775 cites W1973098539 @default.
- W4381432775 cites W1976467447 @default.
- W4381432775 cites W1977756163 @default.
- W4381432775 cites W1977858494 @default.
- W4381432775 cites W1981175059 @default.
- W4381432775 cites W1982384502 @default.
- W4381432775 cites W1986799021 @default.
- W4381432775 cites W1987964412 @default.
- W4381432775 cites W1988658785 @default.
- W4381432775 cites W1988893231 @default.
- W4381432775 cites W1993808297 @default.
- W4381432775 cites W1994004735 @default.
- W4381432775 cites W1998926000 @default.
- W4381432775 cites W1999352112 @default.
- W4381432775 cites W2002697168 @default.
- W4381432775 cites W2003429874 @default.
- W4381432775 cites W2007616480 @default.
- W4381432775 cites W2009710456 @default.
- W4381432775 cites W2009974403 @default.
- W4381432775 cites W2011367067 @default.
- W4381432775 cites W2013201041 @default.
- W4381432775 cites W2015312906 @default.
- W4381432775 cites W2018009819 @default.
- W4381432775 cites W2018741703 @default.
- W4381432775 cites W2020398834 @default.
- W4381432775 cites W2023758332 @default.
- W4381432775 cites W2031084334 @default.
- W4381432775 cites W2032240114 @default.
- W4381432775 cites W2038296497 @default.
- W4381432775 cites W2042973822 @default.
- W4381432775 cites W2047208232 @default.
- W4381432775 cites W2051404275 @default.
- W4381432775 cites W2053374578 @default.
- W4381432775 cites W2054202826 @default.
- W4381432775 cites W2056661598 @default.
- W4381432775 cites W2059201273 @default.
- W4381432775 cites W2059265707 @default.
- W4381432775 cites W2061142336 @default.
- W4381432775 cites W2064297038 @default.
- W4381432775 cites W2064657535 @default.
- W4381432775 cites W2065181822 @default.
- W4381432775 cites W2066685510 @default.
- W4381432775 cites W2066734716 @default.
- W4381432775 cites W2068650301 @default.
- W4381432775 cites W2069016591 @default.
- W4381432775 cites W2073765250 @default.
- W4381432775 cites W2075370669 @default.
- W4381432775 cites W2080132632 @default.
- W4381432775 cites W2081306620 @default.
- W4381432775 cites W2084141237 @default.
- W4381432775 cites W2084372772 @default.
- W4381432775 cites W2086385875 @default.
- W4381432775 cites W2086388499 @default.
- W4381432775 cites W2087032263 @default.
- W4381432775 cites W2088394403 @default.
- W4381432775 cites W2093165790 @default.
- W4381432775 cites W2095282566 @default.
- W4381432775 cites W2096459042 @default.
- W4381432775 cites W2101203073 @default.
- W4381432775 cites W2103667120 @default.
- W4381432775 cites W2106116627 @default.
- W4381432775 cites W2106207488 @default.
- W4381432775 cites W2107985777 @default.
- W4381432775 cites W2110115130 @default.
- W4381432775 cites W2111463416 @default.
- W4381432775 cites W2113120391 @default.
- W4381432775 cites W2117800935 @default.
- W4381432775 cites W2118345813 @default.
- W4381432775 cites W2118906726 @default.
- W4381432775 cites W2119297186 @default.